[1] Bhosale P , Peungjesada S, Devine C. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma[J]. Comput Assist Tomogr , 2010, 34(6) : 855-864.[2] Quinn MA, Benedet JL, Odicino F. Carcinoma of the cervix uteri FIGO 6th annual report on the results of treatment in gynecological cancer[J].Gynaecol Obstet ,2006,95(Suppl 1):S43-S103.[3] Odicino F, Pecorelli S, Zigliani L. History of the FIGO cancer staging system[J]. Gynaecol Obstet ,2008,101:205-210.[4] Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix[J].Gynaecol Obstet ,2009,105:107-108.[5]http://www.nccn.org/professionals/physician_gls/PDF/cervical.pdf 2009; volume 1.[6] Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging [J] .Nucl Med, 2004, 45:1509-1518.[7] Luis Martí-Bonmatí.Lymph node assessment by diffusion weighted imaging in cervical cancer[J].Eur Radiol,2011, 21:474-479.[8] Chen YB, Liao J, Xie R,et al. Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging[J]. Abdom Imaging ,2011, 36:102-109.[9] Chung HH, Kang KW, Cho JY. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer[J]. Obstet Gynecol,2010,203:156.e1-e5.[10] Bipat S, Glas AS, Zwinderman AH, et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review[J]. Gynecol Oncol,2003,91:59-66.(2014-10-02收稿 2014-12-01修回) |